Stockreport

Akcea and Ionis Report Positive Data from Phase 2 Study of AKCEA-APO(a)-LRx

AKCEA THERAPEUTICS  (AKCA) 
Last akcea therapeutics earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.akceatx.com/media-investors/press-releases
PDF Study demonstrates significant Lp(a) reduction, favorable safety and tolerability profile [Read more]